Shares of First Majestic Silver (AG) have gained 5.9% over the past four weeks to close the last trading session at $5.91, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any …
Howard Hughes Holdings (HHH) closed the last trading session at $67.47, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price …
Shares of Iridium Communications (IRDM) have gained 2.4% over the past four weeks to close the last trading session at $25.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …
LifeStance Health Group (LFST) closed the last trading session at $6.80, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price …
Pan American Silver (PAAS) closed the last trading session at $23.54, gaining 9.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price …
Xenon Pharmaceuticals (XENE) closed the last trading session at $38.28, gaining 30.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …
Shares of Equinox Gold (EQX) have gained 4.3% over the past four weeks to close the last trading session at $6.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …
Alibaba (BABA) closed the last trading session at $125.76, gaining 7.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …
Edison International (EIX) closed the last trading session at $54.88, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …
Shares of Apogee Therapeutics Inc. (APGE) have gained 24.1% over the past four weeks to close the last trading session at $40.12, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any …